Reply  by Lombardi, Joseph V.
LETTERS TO THE EDITOR
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pRegarding “Operative salvage of radiocephalic
arteriovenous fistulas by formation of a proximal
neoanastomosis”
We congratulate the authors on their 90% radial cephalic fistula
rate and the good results obtained by surgical correction of malfunc-
tioning arteriovenous fistulas using a proximal neoanastomosis.1
However, we would like to make the following observations:
The authors do not indicate the site of stenosis that caused the
fistula failure. In most patients with stenosis of the fistula, the lesion
will be in the swing segment.2 Even in those that are classed as an
anastomotic stenosis (ie, at or2 cm on either side of the anastomo-
sis), more than half of the lesions will be on the venous side.3
In our experience, many of these patients will have an intact
dorsal cephalic branch. By using this branch to perform a Yarl 2
vein flap fistuloplasty,4 the stenosis can be corrected with excellent
outcomes. Creating a neoanastomosis will create a new swing
segment, with its attendant problems. Therefore, we respectfully
submit that in carefully selected patients, vein flap fistuloplasty
should be considered before a proximal neoanastomosis.
Anantha K. Ramanathan, MBBS
Department of Vascular Surgery
Central Coast Health
Gosford, New South Wales, Australia
Justin A. Roake, MBChB, DPhil
Department of Vascular Surgery
Christchurch Hospital
Christchurch, New Zealand
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Reply
We thank Ramanathan and Roake for their interest in our
recent article. We agree that many of the venous stenoses that led
to proximal revision may well have been in the swing segment,
although we were unable to record this in our article as this
information was not recorded prospectively. Although the Yarl
fistuloplasty may be of use in nonthrombosed fistulas where a
nearby venous tributary is present, 25 of the 81 patients in our
series had revision for thrombosis. In our experience, venous
collaterals of a sufficient size near a perianastomotic stenosis are
uncommon, further limiting the utility of this technique. Unfor-
tunately, the article quoted by the correspondents does not de-
scribe complications or outcomes with the Yarl fistuloplasty.
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egarding “An all-inclusive and transparent view of a
ascular program’s direct impact on its health system”
Taylor et al1 present a useful review of a vascular surgery
ervice line impact on hospital revenue. Such information is critical
hen approaching hospital administration for service-related cap-
tal requests, contracting discussions, and programmatic develop-
ent. The reporting of financial data, however, is variable and
epresents a multitude of factors on both the revenue and cost
ides.
Revenue is highly dependent on payer mix, insurance con-
racting, and regional differences in Medicare payment rates. As
uch, methodologic translation to other health systems may be
ifficult, particularly when exploring cost-to-revenue ratios and
ther service-related metrics. To account for these variations, the
se of payer neutral revenue (PNR) has been suggested.2
Briefly, PNR methodology “corrects” for payer status and
ssumes that all revenue would be derived from published standard
edicare rates. Although this does not identify true revenue
ollars per se, it is a powerful tool for identifying cost variations
ithin and across health systems, managing practice variability,
mproving operation efficiency, and planning for potential future
ecreases in reimbursement. Armed with such data, service line
est practices and improved efficiency can be presented to leader-
hip immune to differences in payer status and mix. For example,
lthough vascular surgery net revenue at a large suburban hospital
ay be high compared with a smaller inner-city institution due to
ayer mix, evaluation using a PNRmethod can highlight unrecog-
ized fiscal efficiency with regard to cost, an important factor in
ospital operations. I suggest that the Journal of Vascular Surgery
nd other peer-reviewed medical publications adopt standardized
ost and revenue methodology to broaden translation across
ealth systems.
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The use of payer neutral revenue methodology levels the
laying field when it comes to revenue, and when reporting across
ifferent health systems for comparison, it makes great sense.
here are some issues on the cost side, however: All facilities have
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Volume 56, Number 1 Letters to the Editor 281different cost structures, and high costs can be secondary to a
variety of issues not necessarily related to operational inefficiencies.
For example, health systems that are building programs may be in
an investment and growth phase investing in new talent or tech-
nology. Depending on when you analyze such a program, the
profit and loss sheets may look dismal. Hence, the maturity of a
program must be given some consideration in the analysis. For
future studies, payer neutral revenue alone, aside from direct costs
and contribution margins, will allow everyone to compare their
apples, so to speak. You can still show the value of a program
without getting into cost issues that are not applicable to everyone.
That aside, our authors have a healthy desire to know what the
vascular surgical contribution margin is and how it compares with
the other “valued” programs in our health system. Our report is a
snapshot of one particular health system encompassing the rela-
tionships between different programs in the eyes of the adminis-
trators. We would welcome other health systems to corroborate
our findings and strengthen the overall perception and value of
vascular surgical programs across the country.
Joseph V. Lombardi, MD
Chief of Vascular and Endovascular Surgery
Cooper University Hospital
Camden, NJ
Associate Professor of Surgery
Cooper Medical School of Rowan University
Camden, NJ
doi:10.1016/j.jvs.2012.02.044
Simple routine assessment of dietary pattern in
patients with peripheral artery disease
Atherosclerosis is a systemic disease that affects coronary,
cerebral, and lower extremity arteries and requires stringent sec-
ondary preventive measures to prevent premature mortality and
morbidity.1 Diet is one of the environmental factors, which plays a
role in atherosclerosis development. Logically, the guidelines rec-
ommend diet assessment and management, specifically in second-
ary prevention.2 Unfortunately, most of the available tools (diet
records, diet interviews etc) to evaluate individual diet remain too
complicated and time-consuming to be easily used in clinical
practice. A simple 14-item food frequency questionnaire (FFQ)
was recently validated against a 7-day dietary history and against
biomarkers.3 It has previously shown its interest in coronary heart
disease and in ischemic stroke associated with carotid atheroscle-
rosis.3,4 Its applicability in clinical practice has not been tested in
patients with lower limb peripheral artery disease (PAD).
We conducted a cross-sectional study in PAD patients with
intermittent claudication referred for a walking treadmill test (3.2
km/h; 10%). The study received the ethics committee agreement
of the University Hospital of Angers, France.
PAD was established measuring ankle-brachial index (ABI)
with a hand-held Doppler probe. The lowest ABI was used in this
study. Maximal walking distance on treadmill was also recorded.
Before treadmill test, patients were invited to self-complete
the FFQ. Incomplete FFQs were corrected by patient interview
after treadmill test completion. This FFQ provides scores for
characteristic food groups involved in atherosclerosis disease
(scores for saturated fatty acids [SFA], mono-unsaturated fatty
acids [MUFA], n-3 poly-unsaturated fatty acids [n-3 PUFA], and
for fruit and vegetables [F&V]) as well as a global vascular dietary
score (VDS). VDS is calculated as (MUFA  n- 3PUFA  F&V)
– SFA scores.5 VDS gives an estimation of the dietary pattern
graded from 17 to 19. The higher the score, the more favor-
able was the dietary pattern.
Thirty-five patients were included. Among these 35 patients,
21 (60%) had a history of vascular atherosclerotic disease. Patients
need approximately 10 minutes to complete the FFQ. Incomplete
s
aFQs were corrected in six patients (17%). Patient characteristics
re presented in Table I. Only five (14%) had had previous nutri-
ional advice.
Using the FFQ, we showed that quick dietary assessment can
e routinely performed inmost PAD patients in10minutes. Our
esults indicated that PAD patients had an unfavorable dietary
attern, characterized by a high consumption of SFA and low
onsumptions of F&V, n-3PUFA, and MUFA.
It is important to point out that no prospective cohort study
as determined clinical cut-offs and ranges for the VDS and other
ubscale scores. However, according to previous studies,3-5 a mean
DS of 7 to 8 can be considered as an optimal dietary score,
hich is potentially related to a favorable vascular diet against
ascular diseases. Indeed, a VDS 7 corresponds to a high con-
umption of F&V, MUFA, n-3 PUFA, and a low consumption of
FA. Consequently, all patients with a VDS  7 need dietary
dvice for vascular dietary improvement. Specifically, a VDS 1
an be considered as a risky vascular diet because a VDS of1 was
reviously found to be associated with acute coronary heart dis-
ase, and a worse VDS was found in ischemic stroke patients and
arotid atherosclerosis.3,4
Beyond the sole VDS calculation, the FFQ provides subscale
cores that enable practitioner to give better specific nutritional
dvice to the patient (Table II). These results are in accordance
ith the work of Gardner et al in which patients recorded their
ood intake for 7 days.6 In our study, it is notable that most patients
60%) had previously been diagnosed with atherosclerosis and, as
uch, should have benefited from dietary advice.2 This study
able I. Patient characteristics
PAD patients
(n  35)
ge, years 63  13
ale sex, No. (%) 29 (83)
ody mass index (kg/m2) 27.7  3.9
urrent or former smoker, No. (%) 30 (86)
ascular history
Lower extremities vascular surgery, No. (%) 9 (26)
Carotid endarterectomy, No. (%) 12 (34)
Coronary artery bypass surgery or stenting,
No. (%) 4 (11)
Aorta surgery, No. (%) 4 (11)
reatments
Antiplatelets, No. (%) 27 (77)
Anticoagulants, No. (%) 1 (3)
Anticholesterols, No. (%) 23 (66)
Angiotensin-converting enzyme inhibitors,
No. (%) 9 (26)
Other antihypertensives, No. (%) 23 (66)
Oral antidiabetics, No. (%) 6 (17)
Ankle brachial index 0.69  0.22
Self-reported maximal walking distance
(in meters) 458  358
Treadmill maximal walking distance (in meters) 347  362
ietary scores
MUFA, ranging from 0 to 4 points 1.2  1.1
n-3 PUFA ranging from 0 to 8 points 3.1  2.8
F&V ranging from 0 to 7 points 2.9  1.4
SFA ranging from 0 to 17 points 4.8  2.9
VDS ranging from 17 to 19 points 2.4  5.8
&V, Fruit and vegetables; MUFA, mono-unsaturated fatty acids; n-3
UFA, omega 3 poly-unsaturated fatty acids; SFA, saturated fatty acids;
DS, vascular dietary score.
esults are expressed as mean  standard deviation.hould encourage physicians and surgeons to perform dietary
ssessment in patients with PAD (Table II). Future randomized
